Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNGX | TANGO THERAPEUTICS INC | $149.19M | $42.07M | -$123.85M | -$130.30M | -$1.19 | 15.17% | 11.28% | N/A | N/A | 2025-05-06 | ||
| VERA | VERA THERAPEUTICS INC | $1.35B | $0.00 | -$142.35M | -$152.15M | -$2.75 | N/A | N/A | N/A | N/A | 2025-05-15 | ||
| HUT | HUT 8 CORP | $1.11B | $162.39M | $526.51M | $331.88M | $3.71 | 294.70% | N/A | 50.81% | N/A | |||
| LBTYA | LIBERTY GLOBAL LTD | $3.60B | $4.34B | $3.13B | $1.59B | $4.33 | 5.49% | -17.14% | N/A | -23.31% | 2025-04-29 | ||
| CEVA | CEVA INC | $539.93M | $106.94M | $1.38M | -$8.79M | -$0.37 | 9.77% | 4.18% | N/A | N/A | 2025-05-07 | ||
| AKA | AKA BRANDS HOLDING CORP | $84.16M | $574.70M | $15.21M | -$25.99M | -$2.46 | 5.21% | 41.19% | N/A | N/A | 2025-05-22 | ||
| PRO | PROS HOLDINGS INC | $750.62M | $330.37M | -$10.86M | -$20.48M | -$0.43 | 8.78% | 5.71% | N/A | N/A | 2025-05-05 | ||
| CGTX | COGNITION THERAPEUTICS INC | $22.56M | $0.00 | -$33.68M | -$33.97M | -$0.86 | N/A | N/A | N/A | N/A | 2025-06-06 | ||
| PRCH | PORCH GROUP INC | $559.50M | $437.85M | $37.35M | -$32.83M | -$0.33 | 1.75% | 41.35% | N/A | N/A | 2025-06-12 | ||
| FVR | FRONTVIEW REIT INC | $351.68M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| MSTR | MICROSTRATEGY INC | $81.78B | $463.46M | -$1.85B | -$1.17B | -$6.06 | -6.61% | -0.96% | N/A | N/A | 2025-04-28 | ||
| TECX | TECTONIC THERAPEUTIC INC | $334.44M | $0.00 | -$55.80M | -$57.98M | -$6.83 | N/A | N/A | N/A | N/A | 2025-05-07 | ||
| CAR | AVIS BUDGET GROUP INC | $2.83B | $11.79B | $1.74B | -$1.82B | -$51.23 | -1.82% | 5.15% | N/A | N/A | 2025-04-29 | ||
| CYBN | CYBIN INC | $145.81M | $0.00 | -$71.77M | -$72.16M | -$3.41 | N/A | N/A | N/A | N/A | |||
| SGMT | SAGIMET BIOSCIENCES INC | $76.95M | $0.00 | -$45.42M | -$45.57M | -$1.45 | -100.00% | N/A | N/A | N/A | |||
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | $77.06M | $0.00 | -$37.75M | -$40.21M | -$3.68 | N/A | -100.00% | N/A | N/A | 2025-05-05 | ||
| ETNB | 89BIO INC | $915.32M | $0.00 | -$360.34M | -$367.08M | -$3.51 | N/A | N/A | N/A | N/A | 2025-05-07 | ||
| ASUR | ASURE SOFTWARE INC | $245.78M | $119.79M | $13.71M | -$11.77M | -$0.45 | 0.60% | 10.37% | N/A | N/A | 2025-04-30 | ||
| IPSC | CENTURY THERAPEUTICS INC | $46.46M | $6.59M | -$111.47M | -$126.57M | -$1.61 | 194.81% | N/A | N/A | N/A | |||
| AVBP | ARRIVENT BIOPHARMA INC | $664.68M | $0.00 | -$80.49M | -$80.49M | -$2.56 | N/A | N/A | N/A | N/A | |||
| IMVT | IMMUNOVANT INC | $2.46B | $0.00 | -$381.48M | -$382.71M | -$2.62 | N/A | N/A | N/A | N/A | |||
| GHRS | GH RESEARCH PLC | $477.10M | $0.00 | -$37.93M | -$38.96M | -$0.75 | N/A | N/A | N/A | N/A | |||
| CNTA | CENTESSA PHARMACEUTICALS PLC | $1.62B | $0.00 | -$221.88M | -$235.76M | -$2.06 | -100.00% | N/A | N/A | N/A | |||
| PONY | PONY AI INC | $1.46B | $75.03M | N/A | -$274.12M | -$2.40 | 4.35% | N/A | N/A | N/A | |||
| BNTC | BENITEC BIOPHARMA INC | $323.63M | $0.00 | -$20.55M | -$22.03M | -$0.01 | -100.00% | N/A | N/A | N/A | 2025-05-12 | ||
| LUCD | LUCID DIAGNOSTICS INC | $108.90M | $4.35M | -$44.34M | -$53.03M | -$1.05 | 79.00% | N/A | N/A | N/A | 2025-05-12 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.